Filing Details

Accession Number:
0001209191-20-051631
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-23 09:20:25
Reporting Period:
2020-09-22
Accepted Time:
2020-09-23 09:20:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1359931 Protara Therapeutics Inc. TARA Biological Products, (No Disgnostic Substances) (2836) 204580525
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1802188 Blaine Davis C/O Artara Therapeutics, Inc.
1 Little West 12Th Street
New York NY 10014
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-22 1,481 $16.91 1,481 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.885 to $16.935, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.